Imiglucerase injection
Imiglucerase injection
What is this medicine?
IMIGLUCERASE (i mi GLOO ser ace) is a man-made form of an enzyme that is missing in patients with Gaucher's disease. It is used to treat the symptoms of Gaucher's disease. It is not a cure.
How should I use this medicine?
This medicine is for infusion into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 2 years old for selected conditions, precautions do apply.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
blue fingernails or lips
breathing problems
chest pain
cough
fast, irregular heartbeat
flushing
low blood pressure
pain at site where injected
swelling of ankles, feet, or hands
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
diarrhea
fever or chills
headache
nausea, vomiting
stomach upset
tiredness
What may interact with this medicine?
miglustat
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
an unusual or allergic reaction to imiglucerase, other medicines, foods, dyes, or preservatives
pregnant or are trying to get pregnant
breast-feeding
What should I watch for while using this medicine?
Visit your doctor for regular checks on your progress. Tell your doctor or healthcare professional if your symptoms do not start to get better or if they get worse.
Updated:  
July 17, 2018